- Companies
- Precision Peptide Co
Precision Peptide Co Valuation Multiples
Precision Peptide Co is valued at $15M as of September 2026. In the last fiscal year, Precision Peptide Co revenue was $36K and Precision Peptide Co EBITDA was ($3M).
Precision Peptide Co Overview
About Precision Peptide Co
Pangea Wellness Inc is a North American manufacturer specializing in clean-label foods and wellness products. Through its subsidiary, the company offers advanced, needle-free peptide therapies that support recovery, cognitive function, and overall health.
Founded
2021
HQ
Employees
2
Website
Sectors
Financials (Last FY)
EV
$14M
Valuation Multiples
Start free trialPrecision Peptide Co Financials
Precision Peptide Co reported last fiscal year revenue of $36K and negative EBITDA of ($3M).
In the same fiscal year, Precision Peptide Co generated $16K in gross profit, ($3M) in EBITDA losses, and had net loss of ($3M).
Precision Peptide Co P&L
In the most recent fiscal year, Precision Peptide Co reported revenue of $36K and EBITDA of ($3M).
Precision Peptide Co is unprofitable as of last fiscal year, with gross margin of 44%, EBITDA margin of (8939%), and net margin of (9104%).
Financial data powered by Morningstar, Inc.
Precision Peptide Co Stock Performance
Precision Peptide Co has current market cap of $15M, and enterprise value of $14M.
Market Cap Evolution
Precision Peptide Co's stock price is $0.31.
Precision Peptide Co has an EPS (earnings per share) of $-0.07.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $14M | $15M | -0.0% | - | - | - | $-0.07 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPrecision Peptide Co Valuation Multiples
Precision Peptide Co trades at 392.9x EV/Revenue multiple, and (4.4x) EV/EBITDA.
Precision Peptide Co Financial Valuation Multiples
As of September 22, 2026, Precision Peptide Co has market cap of $15M and EV of $14M.
Precision Peptide Co has a P/E ratio of (4.5x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Precision Peptide Co Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Precision Peptide Co Margins & Growth Rates
In the most recent fiscal year, Precision Peptide Co reported gross margin of 44%, EBITDA margin of (8939%), and net margin of (9104%).
Precision Peptide Co Margins
Data powered by FactSet, Inc. and Morningstar, Inc.
Precision Peptide Co Operational KPIs
Precision Peptide Co's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.8M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
Precision Peptide Co Competitors
Precision Peptide Co competitors include KKO International, Slaturfelag Suourlands, Industrias Productos Alimenticios, Ecomiam, HYTN Innovations, Hipromine, Epsium Enterprise, Lohilo Foods, Kafelaku Coffee Holding and Vitaminka.
Most Precision Peptide Co public comparables operate across Food & Beverages.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $20M | $3M | 1.1x | - | 7.3x | - | |||
| $159M | $16M | 0.1x | - | 0.9x | - | |||
| $144M | $11M | - | - | - | - | |||
| $45M | ($3M) | 0.3x | 0.3x | (4.3x) | (5.1x) | |||
| $1M | ($823K) | 11.8x | - | (17.1x) | - | |||
| $3M | ($5M) | 19.2x | - | (11.2x) | - | |||
| $5M | ($1M) | 2.9x | - | (9.9x) | - | |||
| $19M | $601K | 0.8x | - | 23.9x | - | |||
This data is available for Pro users. Sign up to see all Precision Peptide Co competitors and their valuation data. Start Free Trial | ||||||||
Acquisitions by Precision Peptide Co
Precision Peptide Co has acquired 2 companies to date.
Last acquisition by Precision Peptide Co was on April 9th 2025. Precision Peptide Co acquired Amino Innovations for $2M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Precision Peptide Co
| Description | Amino Innovations is a wellness products company offering peptide-infused formulations for skin health and personal care. Based in the United States, it develops topical solutions like serums and creams harnessing short-chain peptides to promote collagen production, reduce wrinkles, and enhance hydration. Key products target anti-aging, recovery, and performance optimization through bioavailable amino acid complexes derived from natural sources. The brand emphasizes clean ingredients free from parabens and emphasizes clinical backing for efficacy in retail channels. | Glory Juice Co is a New York City-based producer of organic cold-pressed juices and plant-based wellness shots. The company sources ingredients from local farms in upstate New York and distributes through cafes, gyms, and online subscriptions in the Northeast United States. Glory Juice Co offers flavors like green juice with kale and apple alongside smoothies and tonics. It operates physical locations in Manhattan and Brooklyn emphasizing sustainability through recyclable packaging. |
| HQ Country | ||
| HQ City | Dover, DE | Vancouver |
| Deal Date | 9 Apr 2025 | 24 Apr 2023 |
| Valuation | $2M | $1M |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Precision Peptide Co acquisitions and their M&A valuation multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Precision Peptide Co
| When was Precision Peptide Co founded? | Precision Peptide Co was founded in 2021. |
| Where is Precision Peptide Co headquartered? | Precision Peptide Co is headquartered in Canada. |
| How many employees does Precision Peptide Co have? | As of today, Precision Peptide Co has over 2 employees. |
| Who is the CEO of Precision Peptide Co? | Precision Peptide Co's CEO is Pratap Sandhu. |
| Is Precision Peptide Co publicly listed? | Yes, Precision Peptide Co is a public company listed on Canadian Securities Exchange. |
| What is the stock symbol of Precision Peptide Co? | Precision Peptide Co trades under BPC ticker. |
| When did Precision Peptide Co go public? | Precision Peptide Co went public in 2022. |
| Who are competitors of Precision Peptide Co? | Precision Peptide Co main competitors include KKO International, Slaturfelag Suourlands, Industrias Productos Alimenticios, Ecomiam, HYTN Innovations, Hipromine, Epsium Enterprise, Lohilo Foods, Kafelaku Coffee Holding, Vitaminka. |
| What is the current market cap of Precision Peptide Co? | Precision Peptide Co's current market cap is $15M. |
| What is the current revenue of Precision Peptide Co? | Precision Peptide Co's last fiscal year revenue is $36K. |
| What is the current EV/Revenue multiple of Precision Peptide Co? | Current revenue multiple of Precision Peptide Co is 392.9x. |
| Is Precision Peptide Co profitable? | No, Precision Peptide Co is not profitable. |
| How many companies Precision Peptide Co has acquired to date? | As of September 2026, Precision Peptide Co has acquired 2 companies. |
| What was the largest acquisition by Precision Peptide Co? | $2M acquisition of Amino Innovations on 9th April 2025 was the largest M&A Precision Peptide Co has done to date. |
| What companies Precision Peptide Co acquired? | Precision Peptide Co acquired Amino Innovations and Glory Juice Co. |
| In how many companies Precision Peptide Co has invested to date? | Precision Peptide Co hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Precision Peptide Co
Lists including Precision Peptide Co
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




